Ausgabe 1/2016
Inhalt (13 Artikel)
Mitigation of normal tissue radiation injury: evidence from rat radiation nephropathy models
Eric P. Cohen, Brian L. Fish, John D. Imig, John E. Moulder
Radiation emergencies: radiation-related brain and lung injury
Matthew S. Ning, Joseph M. Kaminski, Darko Pucar, Eric T. Shinohara
Role of thrombocytopenia in radiation-induced mortality and review of therapeutic approaches targeting platelet regeneration after radiation exposure
Andrea L. DiCarlo, Joseph M. Kaminski, Richard J. Hatchett, Bert W. Maidment
Outcomes of symptomatic compared to asymptomatic recurrences in patients with glioblastoma multiforme (GBM)
Arya Amini, Basel Altoos, Sana D. Karam, Timothy V. Waxweiler, Chad G. Rusthoven, Laurie E. Gaspar, Justin M. Honce, Denise M. Damek, Douglas E. Ney, D. Ryan Ormond, Kevin O. Lillehei, Changhu Chen, Brian D. Kavanagh, Arthur K. Liu
A study of the factors affecting radiation-induced temporomandibular joint changes in post-radiotherapy nasopharyngeal carcinoma patients
Vincent W. C. Wu, Michael T. C. Ying, S. Y. Tam, Dora L. W. Kwong
Function preservation and optimal outcomes—definitive chemoradiotherapy with multi-phase treatment planning for locally advanced sinonasal cancer
Lindsay M. Burt, Richard R. Orlandi, Jason P. Hunt, Luke O. Buchmann, Kenneth F. Grossman, Marcus M. Monroe, Dennis C. Shrieve, Ying J. Hitchcock
Quantitative assessment of target delineation variability for thymic cancers: agreement evaluation of a prospective segmentation challenge
Emma Holliday, Clifton D. Fuller, Jayashree Kalpathy-Cramer, Daniel Gomez, Andreas Rimner, Ying Li, Suresh Senan, Lynn D. Wilson, Jehee Choi, Ritsuko Komaki, Charles R. Thomas Jr.
Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for liver stereotactic ablative body radiotherapy
Isabelle Thibault, Matt Wronski, Renée Korol, William Chu, Joelle Helou, Darby Erler, Hans T. Chung
Low-dose aspirin mitigates acute radiation-induced genitourinary toxicity in patients with prostate adenocarcinoma
J. L. Mikell, W. A. Hall, D. C. Nickleach, Y. Liu, N. Jegadeesh, P. J. Rossi, A. B. Jani
Interval to biochemical failure is prognostic for distant metastases after salvage radiation therapy for prostate cancer
Nicholas George Zaorsky, Tianyu Li, Aruna Turaka, David Y. T. Chen, Eric M. Horwitz, Mark K. Buyyounouski
Ten-year outcomes for prostate cancer patients with Gleason 8 through 10 treated with external beam radiation and high-dose-rate brachytherapy boost in the PSA era
Alvaro A. Martinez, Chirag Shah, Nasiruddin Mohammed, D. Jeffrey Demanes, Razvan Galalae, Rafael Martinez-Monge, Mihai Ghilezan, Hong Ye
Predictors of long-term survival for localized prostate cancer treated with high-dose IMRT stratified by NCCN 2015 guidelines in a community hospital setting
Anthony Ricco, Rachelle Lanciano, Alexandra Hanlon
Re-implantation following suboptimal dosimetry in low-dose-rate prostate brachytherapy: technique for outpatient source insertion using local anesthesia
Rachit Kumar, Yi Le, Theodore Deweese, Daniel Y. Song